Caplacizumab | m-entrepreneurship.com

Product Name :
Caplacizumab

Search keywords :
von Willebrand Factor

drugId :
null

Target Vo:
Von willebrand factor

Target Vo Short Name :
vWF

Moa_Name:
Von willebrand factor inhibitors

First Approval Country :
EU

First Approval Date Filter:
2018

Origin Company_Name :
Ablynx Nv

Active Company_Name :
Ablynx Nv

Active Indication_Name:
Acquired thrombotic thrombocytopenic purpura

In Active Indication_Name:
Angina, Unstable

Termination Status :

China Termination Status :

Highest Status:
Approved

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AKT1/AKT2/AKT3 Antibody (YA635)
FMRP Antibody
TNF Receptor 2 Antibody: TNF Receptor 2 Antibody is a non-conjugated and Rabbit origined polyclonal antibody about 48 kDa, targeting to TNF Receptor 2. It can be used for WB,IHC-F,IHC-P,ICC/IF,FC,IP assays with tag free, in the background of Human, Mouse, Rat.

Author: Betaine hydrochloride

Related Posts